Your browser doesn't support javascript.
loading
Response to inquiry by Gaylinn et al. on 'Administration of UAG improves glycemic control in obese subjects with diabetes'.
Özcan, Behiye; Neggers, Sebastian J C M M; Miller, Anne Reifel; Yang, Hsiu-Chiung; Lucaites, Virginia; Abribat, Thierry; Allas, Soraya; Huisman, Martin; Visser, Jenny A; Themmen, Axel P N; Sijbrands, Eric J G; Delhanty, Patric J D; van der Lely, Aart Jan.
Afiliación
  • Özcan B; Department of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
  • Neggers SJ; Department of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
  • Miller AR; Department of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
  • Yang HC; Department of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France yang_hsiu-chiung@Lilly.com.
  • Lucaites V; Department of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
  • Abribat T; Department of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
  • Allas S; Department of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
  • Huisman M; Department of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
  • Visser JA; Department of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
  • Themmen AP; Department of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
  • Sijbrands EJ; Department of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
  • Delhanty PJ; Department of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
  • van der Lely AJ; Department of MedicineErasmus University MC, 3000 CA, Rotterdam, The NetherlandsLilly Research LaboratoriesEli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USAAlizé Pharma69 130 Ecully, France.
Eur J Endocrinol ; 173(1): L3-4, 2015 Jul.
Article en En | MEDLINE | ID: mdl-26026596

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Glucemia / Ghrelina / Obesidad Límite: Female / Humans / Male Idioma: En Revista: Eur J Endocrinol Asunto de la revista: ENDOCRINOLOGIA Año: 2015 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Glucemia / Ghrelina / Obesidad Límite: Female / Humans / Male Idioma: En Revista: Eur J Endocrinol Asunto de la revista: ENDOCRINOLOGIA Año: 2015 Tipo del documento: Article País de afiliación: Francia
...